Edition:
United Kingdom

Boule Diagnostics AB (BOUL.ST)

BOUL.ST on Stockholm Stock Exchange

65.95SEK
20 Feb 2019
Change (% chg)

-1.25kr (-1.86%)
Prev Close
67.20kr
Open
67.00kr
Day's High
68.93kr
Day's Low
64.11kr
Volume
1,053
Avg. Vol
17,638
52-wk High
108.88kr
52-wk Low
50.10kr

Latest Key Developments (Source: Significant Developments)

Boule Diagnostics To Invest EUR 5 Million In biosurfit
Friday, 14 Dec 2018 

Dec 14 (Reuters) - Boule Diagnostics AB ::ENTERED INTO STRATEGIC PARTNERSHIP AND WILL INVEST EUR 5 MILLION IN BIOSURFIT.BOULE DIAGNOSTICS - WILL INITIALLY ACQUIRE SHARES IN BIOSURFIT CORRESPONDING TO 24.99% OF TOTAL SHARE CAPITAL AND NUMBER OF VOTES.  Full Article

Boule Diagnostics Streamlines Production
Friday, 21 Sep 2018 

Sept 21 (Reuters) - Boule Diagnostics AB ::TO STREAMLINE PRODUCTION WITH YEARLY COST REDUCTION SEEN AT SEK 3 MILLION, STARTING FROM Q1 2019.  Full Article

Boule Diagnostics Q2 Operating Profit At SEK 19.8 Million
Wednesday, 15 Aug 2018 

Aug 15 (Reuters) - Boule Diagnostics AB ::Q2 NET SALES SEK 107.8 MILLION VERSUS SEK 104.3 MILLION YEAR AGO.Q2 OPERATING PROFIT SEK 19.8 MILLION VERSUS LOSS SEK 0.7 MILLION YEAR AGO.  Full Article

Boule Diagnostics AB Wins Order In India
Tuesday, 7 Aug 2018 

Boule Diagnostics AB ::WINS ORDER IN INDIA.DELIVERY OF 650 INSTRUMENTS IS EXPECTED TO TAKE PLACE IN Q3 AND Q4 2018.  Full Article

Boule Diagnostics Q3 operating profit grows to SEK ‍28.2​ mln
Wednesday, 8 Nov 2017 

Nov 8 (Reuters) - BOULE DIAGNOSTICS AB ::Q3 NET SALES SEK ‍109.7​ MILLION VERSUS SEK 108.5 MILLION YEAR AGO.Q3 OPERATING PROFIT SEK ‍28.2​ MILLION VERSUS SEK 24.8 MILLION YEAR AGO.  Full Article

BRIEF-Boule Diagnostics Receives Warning Letter From US FDA Authority

* SAID ON FRIDAY UNIT BOULE MEDICAL RECEIVED A WARNING LETTER FROM THE US FOOD AND DRUG ADMINISTRATION